Pharma — December 2021
-
ObsEva: Linzagolix Gets Positive CHMP Opinion For Uterine Fibroids - Quick Facts https://www.proinvestor.com/investornyt/750888/obseva-linzagolix-gets-positive-chmp-opinion-for-uterine-fibroids-quick-facts
-
Ipsen, GENFIT Enter Long-term Collaboration; Ipsen Becomes Shareholder Of GENFIT https://www.proinvestor.com/investornyt/750889/ipsen-genfit-enter-long-term-collaboration-ipsen-becomes-shareholder-of-genfit
-
Basilea Pharma: FDA Allows To Proceed With Phase 1 Study For BAL0891 https://www.proinvestor.com/investornyt/750892/basilea-pharma-fda-allows-to-proceed-with-phase-1-study-for-bal0891
-
CDC Recommends Pfizer, Moderna COVID-19 Vaccines Over J&J Due To Rare Blood Clots https://www.proinvestor.com/investornyt/750860/cdc-recommends-pfizer-moderna-covid-19-vaccines-over-jampj-due-to-rare-blood-clots
-
Merck: CHMP Adopts Positive Opinion For KEYTRUDA As Monotherapy For Adjuvant Treatment Of RCC https://www.proinvestor.com/investornyt/750960/merck-chmp-adopts-positive-opinion-for-keytruda-as-monotherapy-for-adjuvant-treatment-of-rcc
-
Biogen To Seek Re-examination Of
Negative Opinion By EMA For Its 'aducanumab' https://www.proinvestor.com/investornyt/750981/biogen-to-seek-re-examination-of-negative-opinion-by-ema-for-its-aducanumab -
Astellas, Seagen Announce Positive CHMP Opinion For PADCEV - Quick Facts https://www.proinvestor.com/investornyt/750962/astellas-seagen-announce-positive-chmp-opinion-for-padcev-quick-facts
-
Merck KGaA: TEPMETKO Receives CHMP Positive Opinion In Adult Patients With Advanced NSCLC https://www.proinvestor.com/investornyt/751038/merck-kgaa-tepmetko-receives-chmp-positive-opinion-in-adult-patients-with-advanced-nsclc
-
Det undrer mig meget, at ViroGates får så hårdhændet en behandling efter en flot meddelelse om anbefaling af EMA vedr. brug af deres produkt til vurdering af alvorligheden af en Covid19 infektion. Især på baggrund af statsministerens bemærkning i dag om, at regeringen er opmærksom på de medikamenter, der kan være med til at nebringe smitte samt forebygge alvorlig sygdom og indlæggelser.
-
Match...Der bliver solgt ud big time i biotek på gode nyheder. Det har stået i længere tid.
-
PS: Dette er regulær Pharma chat. Virogate passer indtil videre bedst i biotekchatten.
-
Why Novavax Stock Is Jumping Again
Today https://www.proinvestor.com/investornyt/751212/why-novavax-stock-is-jumping-again-todayWhy Novavax Stock Is Jumping Again Today -
FDA Gives Emergency Use Authorization To Pfizer's Covid Treatment Pill https://www.proinvestor.com/investornyt/753312/fda-gives-emergency-use-authorization-to-pfizers-covid-treatment-pill
-
Astrazeneca afslutter milliardaftale om lovende lægemiddelkandidat
https://www.proinvestor.com/investornyt/756199/astrazeneca-afslutter-milliardaftale-om-lovende-laegemiddelkandidat -
2021 blev et stygt år for mange af aktierne i bioteksektoren. Et seriøst bud på årsagerne til dette kan læses i en artikel fra ProInvestors Nasdaq Newsfeed. https://www.proinvestor.com/index.php?p=debat_1&postid=99797
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind